Vaccitech Company
Barinthus Biotherapeutic induces T cells and antibodies to treat and prevent disease.
Investors
Connections from
Founded Date:
2023
Headquarters:
Oxford, Oxfordshire, United Kingdom
Technology:
Personalized Medicine
Employee Number:
4
Industry:
Personalized Medicine
Estimated Revenue:
$13.42 million
Number Of Exists:
N/A
Funding Status:
N/A
Investor Type:
N/A
Investment Stage:
N/A